We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.13%
This Fund
S&P 500
This Quarter Est. Return
+8.04%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
AUM
$2.02B
AUM Growth
+$860M
Cap. Flow
+$640M
Cap. Flow %
31.7%
Top 10 Hldgs %
42.73%
Holding
194
New
66
Increased
11
Reduced
16
Closed
53

Top Sells

Rank Stock Value
1
CCC
CCC Intelligent Solutions
CCC
+$133M
2
DLR icon
Digital Realty Trust
DLR
+$53.7M
3
KVUE icon
Kenvue
KVUE
+$41.4M
4
V icon
Visa
V
+$38M
5
ENB icon
Enbridge
ENB
+$26.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 14.94%
2 Consumer Discretionary 13.06%
3 Technology 12.94%
4 Healthcare 12.07%
5 Real Estate 11.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONT
101
Onterris Inc
ONT
$616M
$1.84M 0.09%
70,000
ADT icon
102
ADT
ADT
$5.14B
$1.81M 0.09%
250,000
GRDN
103
Guardian Pharmacy Services
GRDN
$2.95B
$1.68M 0.08%
+100,000
New +$1.69M
NVGS icon
104
Navigator Holdings
NVGS
$1.51B
$1.61M 0.08%
100,000
ZK
105
DELISTED
Zeekr
ZK
$1.56M 0.08%
70,000
TALO icon
106
Talos Energy
TALO
$2.91B
$1.55M 0.08%
150,000
HG icon
107
Hamilton Insurance Group
HG
$3.47B
$1.45M 0.07%
75,000
-75,000
-50% -$1.34M
CART icon
108
Maplebear
CART
$10.8B
$1.43M 0.07%
35,000
-35,000
-50% -$1.23M
PAL
109
Proficient Auto Logistics
PAL
$134M
$1.42M 0.07%
100,000
-100,000
-50% -$1.81M
CRMT icon
110
America's Car Mart
CRMT
$15.3M
$1.26M 0.06%
+30,000
New +$1.74M
AVBP icon
111
ArriVent BioPharma
AVBP
$1.36B
$1.18M 0.06%
50,000
WVE icon
112
Wave Life Sciences
WVE
$887M
$1.15M 0.06%
+140,000
New +$837K
LOAR icon
113
Loar Holdings
LOAR
$6.06B
$1.12M 0.06%
15,000
+5,000
+50% +$332K
BBIO icon
114
BridgeBio Pharma
BBIO
$13.4B
$859K 0.04%
33,750
SVV icon
115
Savers
SVV
$1.4B
$789K 0.04%
75,000
-75,000
-50% -$764K
MBX
116
MBX Biosciences
MBX
$2.97B
$779K 0.04%
+30,000
New +$686K
ASND icon
117
Ascendis Pharma A/S
ASND
$16.3B
$747K 0.04%
+5,000
New +$675K
SVCO
118
Silvaco Group
SVCO
$221M
$715K 0.04%
50,000
BIOA
119
BioAge Labs
BIOA
$355M
$624K 0.03%
+30,000
New +$601K
GAUZ
120
Gauzy
GAUZ
$9.08M
$554K 0.03%
3,125
-3,076
-50% -$625K
CURV icon
121
Torrid Holdings
CURV
$213M
$393K 0.02%
+100,000
New +$674K
RITM icon
122
Rithm Capital
RITM
$5.29B
$369K 0.02%
+32,488
New +$370K
BCAX
123
Bicara Therapeutics
BCAX
$1.46B
$255K 0.01%
+10,000
New +$255K
MDXH icon
124
MDxHealth
MDXH
$65M
$218K 0.01%
+105,019
New +$285K
PHVS icon
125
Pharvaris
PHVS
$2.64B
$208K 0.01%
+11,249
New +$206K

Similar funds

Ghisallo Capital Management's Q3 2024 Portfolio in Review

As of Q3 2024, Ghisallo Capital Management held 194 positions worth $2.02B, up 74% from $1.16B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Ghisallo Capital Management deployed $640M of net new capital in Q3 2024, opening 66 new positions and adding to 11 existing holdings. Its largest new stake was Diamondback Energy: 700,000 shares worth $121M.

By sector, the portfolio is most concentrated in Miscellaneous at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Technology.

On the sell side, the largest reduction was Digital Realty Trust, an estimated $53.7M trimmed.

  • Ghisallo Capital Management's largest Q3 2024 buy was Diamondback Energy: 700,000 shares worth $121M.
  • Ghisallo Capital Management added most to GE HealthCare in Q3 2024, an estimated $92.3M increase.
  • Ghisallo Capital Management's biggest Q3 2024 reduction was Digital Realty Trust, cutting an estimated $53.7M.
  • Ghisallo Capital Management fully exited CCC Intelligent Solutions in Q3 2024, selling an estimated $133M.
  • Ghisallo Capital Management's ten largest holdings make up 43% of its $2.02B portfolio in Q3 2024.
  • Ghisallo Capital Management opened 66 new positions and closed 53 in Q3 2024.
  • Ghisallo Capital Management's portfolio value rose 74% quarter-over-quarter to $2.02B.

Based on Ghisallo Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.